|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 50, Issue 3 171-183, Copyright © 2000 by American Cancer Society
A. K. Stewart, K. I. Bland, L. S. McGinnis Jr, M. Morrow and H. J. Eyre
The National Cancer Data Base (NCDB) is the empirical data collection and
analysis arm of the American College of Surgeons Commission on Cancer, and
is supported in part by the American Cancer Society. The NCDB collects
oncology patient demographic information, diagnostic and treatment
information, and outcomes data from a broad spectrum of hospital-based
cancer registries throughout the US, ranging from large research and
teaching facilities to small community hospitals. Through this unique
network, data are aggregated and reported back to participating hospitals
to allow individual facilities to evaluate local patient care practices and
outcomes. This article highlights the principal findings of articles
published in 1999 and early 2000 that used NCDB data as the empirical basis
of their analyses. Included among these are articles on breast cancer,
gastric carcinoma, head and neck cancers, leukemia, liver carcinoma, lung
cancer, parathyroid tumors, prostate carcinoma, small bowel adenocarcinoma,
testicular malignancies, and vulvar melanoma. These articles are based on
cases diagnosed between 1985 and 1996. The NCDB has accrued more than 6.4
million cancer cases for this time period. Sufficient numbers of rare
cancers are reported to the NCDB to permit some types of clinical
evaluation not possible using other data sources.
ARTICLES
Clinical highlights from the National Cancer Data Base, 2000
Commission on Cancer, American College of Surgeons, Chicago, IL, USA.
This article has been cited by other articles:
![]() |
C. E. Desch, K. K. McNiff, E. C. Schneider, D. Schrag, J. McClure, E. Lepisto, M. S. Donaldson, K. L. Kahn, J. C. Weeks, C. Y. Ko, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures J. Clin. Oncol., July 20, 2008; 26(21): 3631 - 3637. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ward, M. Halpern, N. Schrag, V. Cokkinides, C. DeSantis, P. Bandi, R. Siegel, A. Stewart, and A. Jemal Association of Insurance with Cancer Care Utilization and Outcomes CA Cancer J Clin, January 1, 2008; 58(1): 9 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goodin, P. Medina, T. Capanna, W. J. Shih, S. Abraham, J. Winnie, S. Doyle-Lindrud, M. Todd, and R. S. DiPaola Effect of Docetaxel in Patients With Hormone-Dependent Prostate-Specific Antigen Progression After Local Therapy for Prostate Cancer J. Clin. Oncol., May 20, 2005; 23(15): 3352 - 3357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Han, D. D. Liu, J. J. Lee, J. Kurie, R. Lotan, W. K. Hong, and H.-Y. Lee 9-cis-Retinoic Acid Treatment Increases Serum Concentrations of {alpha}-Tocopherol in Former Smokers Clin. Cancer Res., March 15, 2005; 11(6): 2305 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Field, J. Cernieux, D. Buist, A. Geiger, L. Lamerato, G. Hart, D. Bachman, R. Krajenta, S. Greene, M. C. Hornbrook, et al. Retention of Enrollees Following a Cancer Diagnosis Within Health Maintenance Organizations in the Cancer Research Network J Natl Cancer Inst, January 21, 2004; 96(2): 148 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kurie, R. Lotan, J. J. Lee, J. S. Lee, R. C. Morice, D. D. Liu, X.-C. Xu, F. R. Khuri, J. Y. Ro, W. N. Hittelman, et al. Treatment of Former Smokers With 9-cis-Retinoic Acid Reverses Loss of Retinoic Acid Receptor-{beta} Expression in the Bronchial Epithelium: Results From a Randomized Placebo-Controlled Trial J Natl Cancer Inst, February 5, 2003; 95(3): 206 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Swanson, C. C. Compton, A. K. Stewart, and K. I. Bland The Prognosis of T3N0 Colon Cancer Is Dependent on the Number of Lymph Nodes Examined Ann. Surg. Oncol., January 1, 2003; 10(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. DiPaola, J. Rinehart, J. Nemunaitis, S. Ebbinghaus, E. Rubin, T. Capanna, M. Ciardella, S. Doyle-Lindrud, S. Goodwin, M. Fontaine, et al. Characterization of a Novel Prostate-Specific Antigen-Activated Peptide-Doxorubicin Conjugate in Patients With Prostate Cancer J. Clin. Oncol., April 1, 2002; 20(7): 1874 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Gregorio, M. Kulldorff, L. Barry, H. Samocuik, and K. Zarfos Geographical Differences in Primary Therapy for Early-Stage Breast Cancer Ann. Surg. Oncol., December 1, 2001; 8(10): 844 - 849. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |